Inside Transaction: Wynnefield Partners Small Cap Value Lp Bought 50,000 Shares of Jason Industries, Inc. (JASN); Bb Biotech Ag Has Upped Its Alder Biopharmaceuticals (ALDR) Position

Wynnefield Partners Small Cap Value Lp is the Jason Industries Inc’s insider that made a purchase of shares of Jason Industries Inc, 50,000 to be precise. The acquired shares were based on $2.8, with Wynnefield Partners Small Cap Value Lp’s transaction having a market value of $137,500 U.S Dollars. Wynnefield Partners Small Cap Value Lp now has rights to 4.68 million shares of Jason Industries Inc.

Bb Biotech Ag increased Alder Biopharmaceuticals Inc. (ALDR) stake by 16.74% reported in 2017Q3 SEC filing. Bb Biotech Ag acquired 325,000 shares as Alder Biopharmaceuticals Inc. (ALDR)’s stock declined 24.25%. The Bb Biotech Ag holds 2.27 million shares with $27.76 million value, up from 1.94 million last quarter. Alder Biopharmaceuticals Inc. now has $1.03 billion valuation. The stock increased 1.68% or $0.25 during the last trading session, reaching $15.15. About 880,239 shares traded. Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR) has declined 33.67% since March 8, 2017 and is downtrending. It has underperformed by 50.37% the S&P500.

Among 16 analysts covering Alder Biopharmaceuticals (NASDAQ:ALDR), 14 have Buy rating, 1 Sell and 1 Hold. Therefore 88% are positive. Alder Biopharmaceuticals had 34 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by RBC Capital Markets on Monday, January 8. The company was maintained on Thursday, February 8 by Canaccord Genuity. The stock of Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR) earned “Buy” rating by Needham on Wednesday, November 8. The rating was maintained by RBC Capital Markets with “Buy” on Monday, October 16. The company was maintained on Thursday, June 29 by Aegis Capital. On Tuesday, March 29 the stock rating was maintained by Credit Suisse with “Outperform”. Canaccord Genuity maintained Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR) on Friday, January 12 with “Buy” rating. Needham maintained Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR) rating on Tuesday, June 27. Needham has “Buy” rating and $3600 target. The firm earned “Buy” rating on Monday, January 8 by BMO Capital Markets. The firm earned “Buy” rating on Wednesday, September 6 by Mizuho.

Jason Industries, Inc., together with its subsidiaries, engages in the manufacture of seating, finishing, acoustics, and components in the United States and internationally. The company has market cap of $79.93 million. It produces finishing products, such as industrial brushes, buffing wheels, and buffing compounds for use in various industrial and infrastructure applications; and supplies seating solutions to equipment manufacturers in the motorcycle, lawn and turf care, industrial, agricultural, construction, and power sports end markets, as well as original equipment maker seating for the heavyweight motorcycles. It currently has negative earnings. The firm also makes engineered non-woven and fiber acoustical products for the auto industry; and makes stamped, formed, expanded and perforated metal components, and subassemblies for rail and filtration applications, outdoor power equipment, small gas engines, and smart utility meters.